These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Utility of Lymphocyte Transformation Test for Assisting Updated Roussel Uclaf Causality Assessment Method in Drug-Induced Liver Injury: A Case-Control Study. Rodríguez A; García-García I; Martínez de Soto L; Gómez López De Las Huertas A; Borobia AM; González-Torbay A; Akatbach-Bousaid I; González-Muñoz M; Ramírez E Front Pharmacol; 2022; 13():819589. PubMed ID: 35370653 [No Abstract] [Full Text] [Related]
26. Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method. Rockey DC; Seeff LB; Rochon J; Freston J; Chalasani N; Bonacini M; Fontana RJ; Hayashi PH; Hepatology; 2010 Jun; 51(6):2117-26. PubMed ID: 20512999 [TBL] [Abstract][Full Text] [Related]
27. Drug properties and host factors contribute to biochemical presentation of drug-induced liver injury: a prediction model from a machine learning approach. Gonzalez-Jimenez A; Suzuki A; Chen M; Ashby K; Alvarez-Alvarez I; Andrade RJ; Lucena MI Arch Toxicol; 2021 May; 95(5):1793-1803. PubMed ID: 33666709 [TBL] [Abstract][Full Text] [Related]
28. Preliminary Results of a Novel Algorithmic Method Aiming to Support Initial Causality Assessment of Routine Pharmacovigilance Case Reports for Medication-Induced Liver Injury: The PV-RUCAM. Scalfaro E; Streefkerk HJ; Merz M; Meier C; Lewis D Drug Saf; 2017 Aug; 40(8):715-727. PubMed ID: 28508325 [TBL] [Abstract][Full Text] [Related]
29. Recurrent drug-induced liver injury (DILI) with ciprofloxacin and amoxicillin/clavulanic. Moreno L; Sánchez-Delgado J; Vergara M; Casas M; Miquel M; Dalmau B Rev Esp Enferm Dig; 2015 Dec; 107(12):767-8. PubMed ID: 26671593 [TBL] [Abstract][Full Text] [Related]
30. Highlights of the drug-induced liver injury literature for 2021. Woo SM; Alhaqqan DM; Gildea DT; Patel PA; Cundra LB; Lewis JH Expert Rev Gastroenterol Hepatol; 2022 Aug; 16(8):767-785. PubMed ID: 35839342 [TBL] [Abstract][Full Text] [Related]
31. Review article: clinical assessment of suspected drug-induced liver injury and its management. Vuppalanchi R; Ghabril M Aliment Pharmacol Ther; 2022 Dec; 56(11-12):1516-1531. PubMed ID: 36282208 [TBL] [Abstract][Full Text] [Related]
32. Susceptibility-Related Cytokine Panel for Prediction of Tu C; Niu M; Wei AW; Tang JF; Zhang L; Jing J; Xiao XH; Wang JB J Inflamm Res; 2021; 14():645-655. PubMed ID: 33692634 [TBL] [Abstract][Full Text] [Related]
33. Metabolomics Profiling and Diagnosis Biomarkers Searching for Drug-Induced Liver Injury Implicated to Huang Y; Zhao X; Zhang ZT; Chen SS; Li SS; Shi Z; Jing J; Huang A; Guo YM; Bai ZF; Zou ZS; Xiao XH; Wang JB; Niu M Front Med (Lausanne); 2020; 7():592434. PubMed ID: 33330552 [No Abstract] [Full Text] [Related]
34. Drug-Induced Liver Injury: Highlights and Controversies in the Recent Literature. Clinton JW; Kiparizoska S; Aggarwal S; Woo S; Davis W; Lewis JH Drug Saf; 2021 Nov; 44(11):1125-1149. PubMed ID: 34533782 [TBL] [Abstract][Full Text] [Related]
35. Avoidability of drug-induced liver injury (DILI) in an elderly hospital cohort with cases assessed for causality by the updated RUCAM score. Danjuma MI; Almasri H; Alshokri S; Khir FK; Elmalik A; Battikh NG; Abdallah IMH; Elshafei M; Fatima H; Mohamed MFH; Maghoub Y; Hussain T; Kamal I; Anwer Z; Bidmos MA; Elzouki AN BMC Geriatr; 2020 Sep; 20(1):346. PubMed ID: 32928134 [TBL] [Abstract][Full Text] [Related]
36. Hepatobiliary and pancreatic: Comparison between Chinese herbal medicine and Western medicine-induced liver injury of 1985 patients. Zhu Y; Niu M; Chen J; Zou ZS; Ma ZJ; Liu SH; Wang RL; He TT; Song HB; Wang ZX; Pu SB; Ma X; Wang LF; Bai ZF; Zhao YL; Li YG; Wang JB; Xiao XH; J Gastroenterol Hepatol; 2016 Aug; 31(8):1476-82. PubMed ID: 26896664 [TBL] [Abstract][Full Text] [Related]
37. Antibiotic-induced liver toxicity: mechanisms, clinical features and causality assessment. Robles M; Toscano E; Cotta J; Lucena MI; Andrade RJ Curr Drug Saf; 2010 Jul; 5(3):212-22. PubMed ID: 20210729 [TBL] [Abstract][Full Text] [Related]
38. Epidemiology of Drug- and Herb-Induced Liver Injury Assessed for Causality Using the Updated RUCAM in Two Hospitals from China. Chen Y; Wang C; Yang H; Huang P; Shi J; Tong Y; Jiang J; Zhang X; Chen W; Xuan Z Biomed Res Int; 2021; 2021():8894498. PubMed ID: 33954202 [TBL] [Abstract][Full Text] [Related]
39. Drug Induced Liver Injury in Geriatric Patients Detected by a Two-Hospital Prospective Pharmacovigilance Program: A Comprehensive Analysis Using the Roussel Uclaf Causality Assessment Method. Pedraza L; Laosa O; Rodríguez-Mañas L; Gutiérrez-Romero DF; Frías J; Carnicero JA; Ramírez E Front Pharmacol; 2020; 11():600255. PubMed ID: 33613279 [No Abstract] [Full Text] [Related]
40. Drug-Induced Liver Injury: Highlights from a Review of the 2015 Literature. Sarges P; Steinberg JM; Lewis JH Drug Saf; 2016 Sep; 39(9):801-21. PubMed ID: 27142208 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]